A Singapore Firm Bets on a US Biotech: What This Means for Your Cross-Border Structure新加坡公司押注美国生物科技：这对您的跨境架构意味着什么

On June 7, 2026, a filing revealed that Capital Group Investment Management PTE. LTD. — the Singapore arm of the US asset manager Capital Group — acquired a $2.53 million stake in Royalty Pharma PLC, a UK-incorporated, US-listed pharmaceutical company. While this news may seems like a routine market transaction, for founders structuring their ventures across the US-China-Hong Kong-Singapore corridor, it serves as a valuable case study in cross-border capital flows, holding company strategy, and tax planning. This signals the tangible pathways through which capital from reputable Asian entities can flow into US businesses, and it highlights the structural considerations that make such investments viable and efficient.

Investment Readiness: Structuring the US Operating Company

For a US-based target to attract institutional capital from Asia, it must be structured in a way that is familiar and efficient for foreign investors. The default choice for most venture-backed and growth-stage companies is the Delaware C-Corp. This structure provides investors with a predictable legal framework, a well-established body of case law, and a clear governance model. Founders expanding from Asia should prioritize establishing their US operating subsidiary as a Delaware C-Corp from the outset. This involves securing an Employer Identification Number (EIN), which can be obtained without an SSN or ITIN via mail or fax though it takes several weeks. Note that under FinCEN’s March 2025 interim final rule, US-formed entities such as a Delaware C-Corp are exempt from Corporate Transparency Act beneficial ownership (BOI) reporting; only foreign-formed companies registered to do business in the US must report. A clean cap table and proper corporate minutes are non-negotiable prerequisites for due diligence, mirroring the standards expected by firms like Capital Group. For those navigating this first-time setup, a thorough Delaware C-Corp setup for foreign founders is an essential resource.

The Holding Company Question: Singapore vs. Traditional Offshore

The news that a Singapore PTE. LTD. is the direct investor is the most instructive part of this announcement. It moves beyond the conventional wisdom of using a Cayman Islands or British Virgin Islands (BVI) holding company. For founders, the choice of a holding jurisdiction has significant implications for tax, reputation, and future strategic flexibility. While BVI/Cayman entities offer low operational overhead and tax neutrality, they are increasingly viewed with regulatory scrutiny. A Singapore holding company, like the one used by Capital Group, offers a compelling alternative. It provides access to one of the world’s most robust tax treaty networks — although, critically, the United States is not part of it: the US has no income tax treaty with Singapore, so dividends, interest, and royalties flowing from the US must be planned around the default 30% withholding (or structured to fit statutory exemptions such as the portfolio interest exemption). While it requires more substance—such as a local director and physical office—the reputational benefits and treaty access often outweigh the higher compliance costs for serious, long-term builders. Deciding between these options is a core component of effective cross-border corporate structuring for SG and HK founders.

Withholding Reality: There Is No US-Singapore Tax Treaty

A Singapore holding company investing in the US gains no treaty-based tax benefits, because the United States has no income tax treaty with Singapore. There is no treaty-reduced withholding rate: US-source dividends paid to a Singapore resident face the default 30% US withholding. (Royalty Pharma plc, incidentally, is UK-incorporated, so US dividend withholding does not apply to its distributions in the first place.) Planning therefore centers on statutory tools rather than treaty relief — for example, the portfolio interest exemption for qualifying debt, structuring income to be non-US-source, or designing exits so returns are realized as capital gains rather than dividends. This is not a checkbox exercise; it requires proactive planning from day one. Founders who assume treaty relief exists could build a structure around a 30% tax drag they never priced in — a costly mistake that erodes shareholder value. This underscores the critical nature of international tax planning and US-China treaty optimization.

Practical Compliance and Next Steps

What should a founder do next after seeing a deal like this? The immediate action is to evaluate your current or intended structure against this real-world example. A China-outbound founder must first secure outbound direct investment (ODI) approval from MOFCOM/SAFE before capital can be legally deployed to a US subsidiary, a step that can take several months. Singapore and Hong Kong founders face fewer outbound capital controls but must still ensure their holding company is properly capitalized and compliant with ACRA or IRD regulations. Once the US entity is established, annual compliance includes federal and state tax returns and franchise tax payments in Delaware (as noted above, US-formed entities are currently exempt from FinCEN BOI reporting). As your group scales, you will need robust systems for transfer pricing documentation to justify intercompany transactions, such as management service fees or IP licensing. The operational complexity is manageable with the right advisory partner, but proactive planning is far more effective than reactive compliance.

YZ CPA Advisory View

One caveat on the headline itself: Capital Group Investment Management Pte. Ltd. is the Singapore subsidiary of the US asset manager Capital Group, and the filing is a routine portfolio disclosure — not Asian capital selecting a treaty-driven structure (no US-Singapore treaty exists). The structuring lesson still stands: reputable, substance-backed holding jurisdictions like Singapore are increasingly favored over opacity-first offshore shells. For Singapore, Hong Kong, and China-outbound founders, this means building a group structure from day one that is not only tax-efficient but also investment-ready from the perspective of a discerning institutional investor.

中文摘要

新加坡投资实体对美国公司的投资，为跨境创业者提供了关于投资准备、持股公司司法管辖区选择以及美国预提税规划的宝贵案例。需注意美国与新加坡之间没有所得税协定，美国来源股息默认适用 30% 预提税；扩展至美国时，应围绕这一现实搭建声誉良好、具备实质的持股结构。